Blog

From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step – Xconomy

From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step
Xconomy
There are plenty of regulatory hurdles, including a number of “safety pitfalls” that CDI “will have to avoid in their march to clinical application,” says Willy Lensch, executive director of Harvard University's department of stem cell and regenerative …
MADISON – Sales rise for stem cell company CDI but so do expensesBizTimes.com (Milwaukee)


Susan A. Willetts Joins Cellular Dynamics' Board of DirectorsGlobeNewswire (press release)

all 8 news articles »

2014-11-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.